Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Braz. j. microbiol ; 46(3): 649-657, July-Sept. 2015. tab, ilus
Article in English | LILACS | ID: lil-755803

ABSTRACT

To facilitate the biodegradation of diesel oil, an oil biodegradation bacterial consortium was constructed. The alkane hydroxylase (alkB) gene of Pseudomonas putida GPo1 was constructed in a pCom8 expression vector, and the pCom8-GPo1 alkB plasmid was transformed into Escherichia coli DH5α. The AlkB protein was expressed by diesel oil induction and detected through SDS-polyacrylamide gel electrophoresis. The culture of the recombinant (pCom8-GPo1 alkB/E. coli DH5α) with the oil biodegradation bacterial consortium increased the degradation ratio of diesel oil at 24 h from 31% to 50%, and the facilitation rates were increased as the proportion of pCom8-GPo1 alkB/E. coli DH5α to the consortium increased. The results suggested that the expression of the GPo1 gene in E. coli DH5α could enhance the function of diesel oil degradation by the bacterial consortium.

.


Subject(s)
Acinetobacter/metabolism , Biodegradation, Environmental , /genetics , Escherichia coli/metabolism , Microbial Consortia/genetics , Organisms, Genetically Modified/metabolism , Pseudomonas putida/enzymology , Acinetobacter/genetics , Escherichia coli/enzymology , Escherichia coli/genetics , Fuel Oils , Gasoline , Genetic Engineering , Oxidation-Reduction , Organisms, Genetically Modified/genetics , Plasmids/genetics , Pseudomonas putida/genetics , Pseudomonas putida/metabolism
2.
Braz. j. microbiol ; 45(4): 1117-1129, Oct.-Dec. 2014. tab
Article in English | LILACS | ID: lil-741261

ABSTRACT

Genetically attenuated microorganisms, pathogens, and some commensal bacteria can be engineered to deliver recombinant heterologous antigens to stimulate the host immune system, while still offering good levels of safety. A key feature of these live vectors is their capacity to stimulate mucosal as well as humoral and/or cellular systemic immunity. This enables the use of different forms of vaccination to prevent pathogen colonization of mucosal tissues, the front door for many infectious agents. Furthermore, delivery of DNA vaccines and immune system stimulatory molecules, such as cytokines, can be achieved using these special carriers, whose adjuvant properties and, sometimes, invasive capacities enhance the immune response. More recently, the unique features and versatility of these vectors have also been exploited to develop anti-cancer vaccines, where tumor-associated antigens, cytokines, and DNA or RNA molecules are delivered. Different strategies and genetic tools are constantly being developed, increasing the antigenic potential of agents delivered by these systems, opening fresh perspectives for the deployment of vehicles for new purposes. Here we summarize the main characteristics of the different types of live bacterial vectors and discuss new applications of these delivery systems in the field of vaccinology.


Subject(s)
Animals , Humans , Bacterial Vaccines/immunology , Drug Carriers , Bacterial Infections/prevention & control , Bacterial Vaccines/genetics , Neoplasms/therapy , Organisms, Genetically Modified/genetics , Organisms, Genetically Modified/immunology , Vaccines, Attenuated/genetics , Vaccines, Attenuated/immunology
3.
Experimental & Molecular Medicine ; : 63-70, 2011.
Article in English | WPRIM | ID: wpr-186267

ABSTRACT

Th-2-biased immune responses are known to play a key role in the pathogenesis of atopic dermatitis. In particular, the macrophage-derived chemokine CCL22 is directly implicated in Th-2-associated skin inflammatory reactions, and its levels are significantly elevated in serum and are correlated with disease severity in atopic dermatitis. In this study, we tested the development of genetic therapeutic options to treat atopic dermatitis using bacteria expressing miRNA. We constructed a recombinant strain of Salmonella typhimurium expressing CCL22 miRNA (ST-miRCCL22) for the in vivo knockdown of CCL22. The CCL22 gene was downregulated with CCL22 miRNA in activated lymphocytes. In mice with a cutaneous disease similar to atopic dermatitis, interleukin-4 was inhibited and interferon-gamma was induced after treatments with ST-miRCCL22. Furthermore, CCL22 levels were suppressed in the atopic mice treated with ST-miRCCL22. These results suggest that ST-miRCCL22 may be an effective genetic agent for treating atopic dermatitis.


Subject(s)
Animals , Female , Mice , Cell Line , Chemokine CCL22/genetics , Cytokines/blood , Dermatitis, Atopic/pathology , Disease Models, Animal , Gene Expression Regulation/drug effects , Gene Silencing , Immunoglobulin E/blood , MicroRNAs/genetics , Organisms, Genetically Modified/genetics , Salmonella typhimurium/genetics , Skin/drug effects
4.
Genet. mol. res. (Online) ; 4(1): 100-104, Mar. 2005.
Article in English | LILACS | ID: lil-417404

ABSTRACT

According to Gestalt thinking, biological systems cannot be viewed as the sum of their elements, but as processes of the whole. To understand organisms we must start from the whole, observing how the various parts are related. In genetics, we must observe the genome over and above the sum of its genes. Either loss or addition of one gene in a genome can change the function of the organism. Genomes are organized in networks of genes, which need to be well integrated. In the case of genetically modified organisms (GMOs), for example, soybeans, rats, Anopheles mosquitoes, and pigs, the insertion of an exogenous gene into a receptive organism generally causes disturbance in the networks, resulting in the breakdown of gene interactions. In these cases, genetic modification increased the genetic load of the GMO and consequently decreased its adaptability (fitness). Therefore, it is hard to claim that the production of such organisms with an increased genetic load does not have ethical implications


Subject(s)
Humans , Animals , Bioethical Issues , Genome , Gestalt Theory , Organisms, Genetically Modified , Organisms, Genetically Modified/genetics , Organisms, Genetically Modified/physiology , Rats
5.
Brasília; Brasil. Ministério da Saúde; 2005. 223 p. ilus.(Série D. Reuniões e conferências).
Monography in Portuguese | LILACS | ID: lil-430270

ABSTRACT

A Biossegurança deve ser entendida como área essencial para pesquisa e desenvolvimento moderno da biotecnologia brasileira. Sendo um campo complexo e transdisciplinar, requer recursos humanos específicos com experiência e capacidade crítica para lidar com os procedimentos de avaliação, além de antecipar cenários futuros. O meio ambiente que circunda o profissional de biossegurança e suas responsabilidades é um espaço importante de preservação de riscos para a população. A atuação do Ministério da Saúde neste âmbito, configura-se de vital importância


Subject(s)
Medical Laboratory Science , Organisms, Genetically Modified/genetics
6.
J Vector Borne Dis ; 2003 Sep-Dec; 40(3-4): 73-7
Article in English | IMSEAR | ID: sea-117938

ABSTRACT

Malaria ranks among the deadliest infectious diseases that kills more than one million persons every year. The mosquito is an obligatory vector for malaria transmission. In the mosquito, Plasmodium undergoes a complex series of developmental events that includes transformation into several distinct morphological forms and the crossing of two different epithelia--midgut and salivary gland. Circumstantial evidence suggests that crossing of the epithelia requires specific interactions between Plasmodium and epithelial surface molecules. By use of a phage display library we have identified a small peptide-SM1--that binds to the surfaces of the mosquito midgut and salivary glands. Transgenic Anopheles stephensi mosquitoes expressing a SM1 tetramer from a blood-inducible and gut-specific promoter are substantially impaired in their ability to sustain parasite development and transmission. A second effector gene, phospholipase A2, also impairs parasite transmission in transgenic mosquitoes. These findings have important implications for the development of new strategies for malaria control.


Subject(s)
Animals , Anopheles/genetics , Humans , Insect Proteins/genetics , Insect Vectors/genetics , Malaria/parasitology , Organisms, Genetically Modified/genetics , Peptide Library , Plasmodium/growth & development , Transformation, Genetic
7.
J Biosci ; 2001 Dec; 26(5): 667-83
Article in English | IMSEAR | ID: sea-110750

ABSTRACT

This article is focused on the problems of reduction of the risk associated with the deliberate release of genetically modified microorganisms (GMMs) into the environment. Special attention is given to overview the most probable physiological and genetic processes which could be induced in the released GMMs by adverse environmental conditions, namely: (i) activation of quorum sensing and the functions associated with it, (ii) entering into a state of general resistance, (iii) activation of adaptive mutagenesis, adaptive amplifications and transpositions and (iv) stimulation of inter-species gene transfer. To reduce the risks associated with GMMs, the inactivation of their key genes responsible for stress-stimulated increase of viability and evolvability is proposed.


Subject(s)
Adaptation, Physiological , Biological Evolution , Gene Transfer, Horizontal , Microbiology , Mutagenesis , Mutation , Organisms, Genetically Modified/genetics , Plasmids
SELECTION OF CITATIONS
SEARCH DETAIL